Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
Abstract There is an ongoing search for new tracers to optimize imaging of beta cell-derived tumors (insulinomas). The PAC1 receptor, expressed by insulinomas, can be used for targeting of these tumors. Here, we investigated whether radiolabeled maxadilan could be used for insulinoma imaging. Maxadi...
Guardado en:
Autores principales: | Lieke Joosten, Maarten Brom, Martin K. H. Schäfer, Otto C. Boerman, Eberhard Weihe, Martin Gotthardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15cd8f038ddf48b98c71877b796995fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3
por: Wael A. Eter, et al.
Publicado: (2017) -
Strategic Evaluation of the Traceless Staudinger Ligation for Radiolabeling with the Tricarbonyl Core
por: Constantin Mamat, et al.
Publicado: (2021) -
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
por: Alessandro Ruggiero, et al.
Publicado: (2010) -
Radiolabeled Bombesin Analogs
por: Rosalba Mansi, et al.
Publicado: (2021) -
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
por: Rangger C, et al.
Publicado: (2012)